← Back to Clinical Trials
Recruiting NCT05418647

NCT05418647 Effect of Low Versus High Dialysate Sodium Concentration During Hemodialysis on Dialysis Recovery Time

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05418647
Status Recruiting
Phase —
Sponsor Alexandria University
Condition Dialysis; Complications
Study Type INTERVENTIONAL
Enrollment 40 participants
Start Date 2025-04-15
Primary Completion 2025-07-15

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
high dialysate Nalow dialysate Na

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 40 participants in total. It began in 2025-04-15 with a primary completion date of 2025-07-15.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This research aims to assess the effect of low versus high dialysate sodium concentration during hemodialysis on dialysis recovery time

Eligibility Criteria

Inclusion Criteria: * Patients with end-stage renal disease who have been prescribed long term hemodialysis and undergo four-hour HD treatments three times a week for more than 90 days. * Patient must be at least 18 years old. They must be able to read and write, as well as be in complete mental health. Exclusion Criteria: * Inability to complete the surveys due to reading or hearing difficulties, actual instability of clinical condition that necessitate hospitalization, dementia, active malignancy or liver failure.

Contact & Investigator

Central Contact

Mohamed Mamdouh Elsayed, MD

✉ dr_mohamedmamdouh87@yahoo.com

📞 00201068055103

Principal Investigator

Mohamed Mamdouh Elsayed, MD

PRINCIPAL INVESTIGATOR

lecturer

Frequently Asked Questions

Who can join the NCT05418647 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Dialysis; Complications. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05418647 currently recruiting?

Yes, NCT05418647 is actively recruiting participants. Contact the research team at dr_mohamedmamdouh87@yahoo.com for enrollment information.

Where is the NCT05418647 trial being conducted?

This trial is being conducted at Alexandria, Egypt, Alexandria, Egypt.

Who is sponsoring the NCT05418647 clinical trial?

NCT05418647 is sponsored by Alexandria University. The principal investigator is Mohamed Mamdouh Elsayed, MD at lecturer. The trial plans to enroll 40 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology